{{Drugbox
| Verifiedfields = 
| Watchedfields = 
| verifiedrevid = 
| IUPAC_name = 1-but-3-en-2-yl-3-(methylcarbamothioylamino)thiourea
| image = Metallibure.svg
| width =

<!--Clinical data-->
| tradename = Aimax, Suisynchron, Turisynchron
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category = 
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = 
| legal_UK = 
| legal_US = 
| legal_status = 
| routes_of_administration =

<!--Pharmacokinetic data-->
| bioavailability = 
| protein_bound = 
| metabolism = 
| elimination_half-life = 
| excretion =

<!-- Identifiers -->
| CAS_number_Ref = 
| CAS_number = 926-93-2
| CAS_supplemental = 
| ATC_prefix = 
| ATC_suffix = 
| ATC_supplemental = 
| PubChem = 3003791
| IUPHAR_ligand = 
| DrugBank_Ref = 
| DrugBank = 
| ChemSpiderID_Ref = 
| ChemSpiderID = 2274191
| UNII = 
| KEGG = 
| ChEBI = 
| ChEMBL =

<!--Chemical data-->
| C=7 | H=14 | N=4 | S=2
| molecular_weight = 218.337 g/mol
| SMILES = CC(C=C)NC(=S)NNC(=S)NC
| StdInChI_Ref = 
| StdInChI = 1S/C7H14N4S2/c1-4-5(2)9-7(13)11-10-6(12)8-3/h4-5H,1H2,2-3H3,(H2,8,10,12)(H2,9,11,13)
| StdInChIKey_Ref = 
| StdInChIKey = CGFFKDRVHZIQHL-UHFFFAOYSA-N
| synonyms = ICI-33828; AY-61122; NSC-69536
}}

'''Metallibure''' ([[International Nonproprietary Name|INN]]) (brand names '''Aimax''', '''Suisynchron''', '''Turisynchron'''; former developmental code names '''ICI-33,828''', '''AY-61122''', '''NSC-69536'''), or '''methallibure''' ([[United States Adopted Name|USAN]], [[British Approved Name|BAN]]) is a [[nonsteroidal]] [[antigonadotropin]] that was introduced in 1973 and is used in [[veterinary medicine]] to synchronize [[estrus]].<ref name="Elks2014">{{cite book|author=J. Elks|title=The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies|url=https://books.google.com/books?id=0vXTBwAAQBAJ&pg=PA781|date=14 November 2014|publisher=Springer|isbn=978-1-4757-2085-3|pages=781–}}</ref><ref name="Gordon2013">{{cite book|author=I. Gordon|title=Controlled Breeding in Farm Animals|url=https://books.google.com/books?id=mEgvBQAAQBAJ&pg=PA313|date=22 October 2013|publisher=Elsevier|isbn=978-1-4832-8569-6|pages=313–}}</ref> It was [[withdrawn drug|withdrawn]] in the [[United States]] and [[Europe]] due to [[teratogen]]icity and has been replaced with [[altrenogest]].<ref name="Gordon2013" /><ref name="pmid19848281">{{cite journal | vauthors = Brüssow KP, Schneider F, Kanitz W, Rátky J, Kauffold J, Wähner M | title = Studies on fixed-time ovulation induction in the pig | journal = Soc Reprod Fertil Suppl | volume = 66 | issue = | pages = 187–95 | year = 2009 | pmid = 19848281 | doi = | url = }}</ref> The precise [[mechanism of action]] of metallibure is unknown.<ref name="Gordon2013" /> However, it appears to act directly on the [[pituitary gland]] and/or [[hypothalamus]] to suppress [[gonadotropin]] [[secretion]].<ref name="Gordon2013" />

Metallibure is similarly effective as an antigonadotropin in women.<ref name="JUCKER2013">{{cite book|author=JUCKER|title=Progress in Drug Research / Fortschritte der Arzneimittelforschung / Progrès des recherches pharmaceutiques|url=https://books.google.com/books?id=Y8HzBwAAQBAJ&pg=PA102|date=21 December 2013|publisher=Birkhäuser|isbn=978-3-0348-7065-8|pages=102–}}</ref> It is associated with several unpleasant [[side effect]]s including [[anorexia (symptom)|anorexia]], [[nausea]], occasional [[vomiting]], [[lethargy]], and [[drowsiness]].<ref name="JUCKER2013" /> Animal [[toxicity]] studies revealed that the drug induced the development of [[cataract]]s, and this resulted in the termination of its [[clinical development]].<ref name="JUCKER2013" />

==See also==
* [[Bifluranol]]
* [[Paroxypropione]]
* [[Quadrosilan]]

==References==
{{reflist|30em}}

{{Gonadotropins and GnRH}}

[[Category:Abandoned drugs]]
[[Category:Antigonadotropins]]
[[Category:Drugs with unknown mechanisms of action]]
[[Category:Withdrawn drugs]]


{{genito-urinary-drug-stub}}